Court curbs Roche sales of Igen products

Maryland Watch

July 29, 1998

Igen International Inc. said yesterday that it has won a court injunction barring Roche Holding AG from selling diagnostic products based on Igen technology to physicians' offices and laboratories run by physicians.

The U.S. District Court in Greenbelt granted the Gaithersburg company's request for the injunction until a lawsuit over Boehringer Mannheim GmbH's sales to physicians is settled, Igen said.

Igen sued Boehringer for breach of contract in September, saying Boehringer's sales to physicians violated a 1992 agreement limiting sales to hospitals, blood banks and clinical reference laboratories. Boehringer was allowed to develop and commercialize diagnostic tests based on Igen technology.

Roche inherited the case when it bought Boehringer's parent company, Corange Ltd., this year, making the Swiss pharmaceutical company the world's largest medical diagnostics company.

The suit also claims that Igen has not been paid full royalties on sales.

Some industry analysts said Igen stands to gain more than $500 million if it wins the case or if a settlement is reached.

Pub Date: 7/29/98

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.